Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
The report details the trend, potential and market size of Epilepsy Diagnosis & Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Epilepsy Diagnosis & Treatmentmarket, defines the market attractiveness level of Epilepsy Diagnosis & Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Epilepsy Diagnosis & Treatment industry, describes the types of Epilepsy Diagnosis & Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Epilepsy Diagnosis & Treatment market and the development prospects and opportunities of Epilepsy Diagnosis & Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Epilepsy Diagnosis & Treatment market in Chapter 13.
By Player:
Abbott
Sanofi
Pfizer
Medtronic
GlaxoSmithKline
Takeda
UCB Pharma
Siemens
Natus Medical
Novartis
Johnson & Johnson
By Type:
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Epilepsy Diagnosis & Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Epilepsy Diagnosis & Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Epilepsy Diagnosis & Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Epilepsy Diagnosis & Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Epilepsy Diagnosis & Treatment Market Analysis and Outlook to 2022
-
7.1 Global Epilepsy Diagnosis & Treatment Consumption (2017-2022)
-
7.2 United States Epilepsy Diagnosis & Treatment Consumption (2017-2022)
-
7.3 Europe Epilepsy Diagnosis & Treatment Consumption (2017-2022)
-
7.4 China Epilepsy Diagnosis & Treatment Consumption (2017-2022)
-
7.5 Japan Epilepsy Diagnosis & Treatment Consumption (2017-2022)
-
7.6 India Epilepsy Diagnosis & Treatment Consumption (2017-2022)
-
7.7 South Korea Epilepsy Diagnosis & Treatment Consumption (2017-2022)
8 Region and Country-wise Epilepsy Diagnosis & Treatment Market Analysis and Outlook to 2028
-
8.1 Global Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
-
8.2 United States Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
-
8.4 China Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
-
8.6 India Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Epilepsy Diagnosis & Treatment Consumption Forecast (2022-2028)
9 Global Epilepsy Diagnosis & Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Epilepsy Diagnosis & Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Diagnosis (Neurological Exam, Blood Test, Imaging) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Treatment (Medication, Surgery) Consumption and Growth Rate (2017-2022)
-
9.2 Global Epilepsy Diagnosis & Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Epilepsy Diagnosis & Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Diagnosis (Neurological Exam, Blood Test, Imaging) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Treatment (Medication, Surgery) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Epilepsy Diagnosis & Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Epilepsy Diagnosis & Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Epilepsy Diagnosis & Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Epilepsy Diagnosis & Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Epilepsy Diagnosis & Treatment Market Competitive Analysis
-
14.1 Abbott
-
14.1.1 Abbott Company Details
-
14.1.2 Abbott Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbott Epilepsy Diagnosis & Treatment Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Epilepsy Diagnosis & Treatment Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Epilepsy Diagnosis & Treatment Product and Service
-
14.4 Medtronic
-
14.4.1 Medtronic Company Details
-
14.4.2 Medtronic Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Medtronic Epilepsy Diagnosis & Treatment Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Product and Service
-
14.6 Takeda
-
14.6.1 Takeda Company Details
-
14.6.2 Takeda Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Epilepsy Diagnosis & Treatment Product and Service
-
14.7 UCB Pharma
-
14.7.1 UCB Pharma Company Details
-
14.7.2 UCB Pharma Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 UCB Pharma Epilepsy Diagnosis & Treatment Product and Service
-
14.8 Siemens
-
14.8.1 Siemens Company Details
-
14.8.2 Siemens Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Siemens Epilepsy Diagnosis & Treatment Product and Service
-
14.9 Natus Medical
-
14.9.1 Natus Medical Company Details
-
14.9.2 Natus Medical Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Natus Medical Epilepsy Diagnosis & Treatment Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Epilepsy Diagnosis & Treatment Product and Service
-
14.11 Johnson & Johnson
-
14.11.1 Johnson & Johnson Company Details
-
14.11.2 Johnson & Johnson Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Epilepsy Diagnosis & Treatment
-
Figure Epilepsy Diagnosis & Treatment Picture
-
Table Global Epilepsy Diagnosis & Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epilepsy Diagnosis & Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epilepsy Diagnosis & Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Epilepsy Diagnosis & Treatment Consumption by Country (2017-2022)
-
Figure United States Epilepsy Diagnosis & Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Epilepsy Diagnosis & Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Epilepsy Diagnosis & Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Epilepsy Diagnosis & Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Epilepsy Diagnosis & Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Epilepsy Diagnosis & Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy Diagnosis & Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Epilepsy Diagnosis & Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnosis (Neurological Exam, Blood Test, Imaging) Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment (Medication, Surgery) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnosis (Neurological Exam, Blood Test, Imaging) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treatment (Medication, Surgery) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Epilepsy Diagnosis & Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Epilepsy Diagnosis & Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Epilepsy Diagnosis & Treatment Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Epilepsy Diagnosis & Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Epilepsy Diagnosis & Treatment Product and Service
-
Table Medtronic (Foundation Year, Company Profile and etc.)
-
Table Medtronic Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Epilepsy Diagnosis & Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Epilepsy Diagnosis & Treatment Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Epilepsy Diagnosis & Treatment Product and Service
-
Table UCB Pharma (Foundation Year, Company Profile and etc.)
-
Table UCB Pharma Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Pharma Epilepsy Diagnosis & Treatment Product and Service
-
Table Siemens (Foundation Year, Company Profile and etc.)
-
Table Siemens Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Epilepsy Diagnosis & Treatment Product and Service
-
Table Natus Medical (Foundation Year, Company Profile and etc.)
-
Table Natus Medical Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natus Medical Epilepsy Diagnosis & Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Epilepsy Diagnosis & Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Epilepsy Diagnosis & Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Epilepsy Diagnosis & Treatment Product and Service
-
